1.
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations
by Thompson, Randall C, Prof
The Lancet (British edition), 2013, Vol.381 (9873), p.1211-1222

2.
Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review
by Peters, Sanne A E
Heart, 2012-02, Vol.98 (3), p.177-184

3.
Intracranial atherosclerosis
by Qureshi, Adnan I, Prof
The Lancet (British edition), 2014, Vol.383 (9921), p.984-998

4.
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
by DeFronzo, R. A
Diabetologia, 2010-04-02, Vol.53 (7), p.1270-1287

5.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

6.
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
by Makowski, Liza
Nature, 2007-07-21, Vol.447 (7147), p.959-965

7.
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wi...
by Reilly, Muredach P, Dr
The Lancet (British edition), 2011, Vol.377 (9763), p.383-392

8.
Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study
by Alonso, Alvaro, MD, PhD
The American heart journal, 2009, Vol.158 (1), p.111-117

9.
High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids
by McMahon, Maureen
Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1619-1624

10.
Lupus Atherosclerosis Prevention Study (LAPS)
by Petri, M A
Annals of the rheumatic diseases, 2011-05, Vol.70 (5), p.760-765

11.
Arterial Stiffness and Hypertension: Chicken or Egg?
by Mitchell, Gary F
Hypertension (Dallas, Tex. 1979), 2014-08, Vol.64 (2), p.210-214

12.
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice
by Panjwani, Naim
Endocrinology (Philadelphia), 2013-01, Vol.154 (1), p.127-139

13.
Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population
by Anderson, Jeffrey L., MD
The American journal of cardiology, 2010, Vol.106 (7), p.963-968

14.
Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study)
by Loehr, Laura R., MD, MS
The American journal of cardiology, 2008, Vol.101 (7), p.1016-1022

15.
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
by Ervinna, Nasib
Endocrinology (Philadelphia), 2013-03, Vol.154 (3), p.1260-1270

16.
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
by Nagashima, M
Diabetologia, 2011-07-24, Vol.54 (10), p.2649-2659

17.
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study
by GRUNFELD, Carl
AIDS (London), 2009, Vol.23 (14), p.1841-1849

18.
Longitudinal Trajectories of Arterial Stiffness and the Role of Blood Pressure: The Baltimore Longitudinal Study of Aging
by AlGhatrif, Majd
Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.934-941

19.
Arterial Stiffness and Hypertension
by Mitchell, Gary F
Hypertension (Dallas, Tex. 1979), 2014-07, Vol.64 (1), p.13-18

20.
Cardiovascular events with absent or minimal coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA)
by Budoff, Matthew J., MD, FACC, FAHA
The American heart journal, 2009, Vol.158 (4), p.554-561
